BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23174883)

  • 21. Identification of clonotypic IgH VDJ sequences in multiple myeloma.
    Taylor BJ; Kriangkum J; Strachan ER; Wizniak J; Pilarski LM
    Methods Mol Med; 2005; 113():121-44. PubMed ID: 15968099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
    Gabrea A; Martelli ML; Qi Y; Roschke A; Barlogie B; Shaughnessy JD; Sawyer JR; Kuehl WM
    Genes Chromosomes Cancer; 2008 Jul; 47(7):573-90. PubMed ID: 18381641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A global expression-based analysis of the consequences of the t(4;14) translocation in myeloma.
    Dring AM; Davies FE; Fenton JA; Roddam PL; Scott K; Gonzalez D; Rollinson S; Rawstron AC; Rees-Unwin KS; Li C; Munshi NC; Anderson KC; Morgan GJ
    Clin Cancer Res; 2004 Sep; 10(17):5692-701. PubMed ID: 15355895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
    Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
    Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3' enhancers does not promote by itself B-cell malignancies.
    Fiancette R; Amin R; Truffinet V; Vincent-Fabert C; Cogné N; Cogné M; Denizot Y
    Leuk Res; 2010 Aug; 34(8):1043-51. PubMed ID: 20018375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NPM1 is overexpressed in hyperdiploid multiple myeloma due to a gain of chromosome 5 but is not delocalized to the cytoplasm.
    Weinhold N; Moreaux J; Raab MS; Hose D; Hielscher T; Benner A; Meissner T; Ehrbrecht E; Brough M; Jauch A; Goldschmidt H; Klein B; Moos M
    Genes Chromosomes Cancer; 2010 Apr; 49(4):333-41. PubMed ID: 20073075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrated analysis of microRNAs, transcription factors and target genes expression discloses a specific molecular architecture of hyperdiploid multiple myeloma.
    Di Martino MT; Guzzi PH; Caracciolo D; Agnelli L; Neri A; Walker BA; Morgan GJ; Cannataro M; Tassone P; Tagliaferri P
    Oncotarget; 2015 Aug; 6(22):19132-47. PubMed ID: 26056083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oligonucleotide-based array CGH as a diagnostic tool in multiple myeloma patients.
    Smetana J; Fröhlich J; Vranová V; Mikulásová A; Kuglik P; Hájek R
    Klin Onkol; 2011; 24 Suppl():S43-8. PubMed ID: 21923064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.
    Gao J; Yang T; Han J; Yan K; Qiu X; Zhou Y; Fan Q; Ma B
    J Cell Biochem; 2011 Jul; 112(7):1844-56. PubMed ID: 21416501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential positioning and close spatial proximity of translocation-prone genes in nonmalignant B-cells from multiple myeloma patients.
    Martin LD; Harizanova J; Zhu G; Righolt CH; Belch AR; Mai S; Pilarski LM
    Genes Chromosomes Cancer; 2012 Aug; 51(8):727-42. PubMed ID: 22489023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-125b-1 and BLID upregulation resulting from a novel IGH translocation in childhood B-Cell precursor acute lymphoblastic leukemia.
    Tassano E; Acquila M; Tavella E; Micalizzi C; Panarello C; Morerio C
    Genes Chromosomes Cancer; 2010 Aug; 49(8):682-7. PubMed ID: 20544842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoglobulin genes in multiple myeloma: expressed and non-expressed repertoires, heavy and light chain pairings and somatic mutation patterns in a series of 101 cases.
    Hadzidimitriou A; Stamatopoulos K; Belessi C; Lalayianni C; Stavroyianni N; Smilevska T; Hatzi K; Laoutaris N; Anagnostopoulos A; Kollia P; Fassas A
    Haematologica; 2006 Jun; 91(6):781-7. PubMed ID: 16769580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14).
    Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G
    Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early genetic events provide the basis for a clinical classification of multiple myeloma.
    Kuehl WM; Bergsagel PL
    Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of primary MAFB target genes in multiple myeloma.
    van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
    Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray.
    Yyusnita ; Norsiah ; Zakiah I; Chang KM; Purushotaman VS; Zubaidah Z; Jamal R
    Malays J Pathol; 2012 Dec; 34(2):133-43. PubMed ID: 23424776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.